SM
KPRX icon

Sabby Management’s Kiora Pharmaceuticals KPRX Stock Holding History

Sabby Management’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,000
Closed -$15.1K – 55
2025
Q1 		$15.1K Buy
+5,000
New +$17.4K 0.04% 43
2024
Q4 		– Sell
-5,000
Closed -$18.3K – 37
2024
Q3 		$18.3K Buy
+5,000
New +$19.5K 0.01% 31
2023
Q3 		– Sell
-34,708
Closed -$201K – 99
2023
Q2 		$201K Buy
+34,708
New +$727K 0.16% 48
2017
Q4 		– Sell
-9
Closed -$54K – 177
2017
Q3 		$54K Sell
9
-55
-86% -$350K ﹤0.01% 150
2017
Q2 		$473K Buy
+64
New +$632K 0.03% 142
2017
Q1 		– Sell
-36
Closed -$314K – 285
2016
Q4 		$314K Sell
36
-58
-62% -$507K 0.02% 226
2016
Q3 		$834K Buy
94
+22
+31% +$236K 0.03% 198
2016
Q2 		$1M Buy
+72
New +$1.25M 0.05% 158
2016
Q1 		– Sell
-42
Closed -$624K – 325
2015
Q4 		$624K Sell
42
-3
-7% -$48.4K 0.03% 221
2015
Q3 		$695K Buy
+45
New +$1.03M 0.03% 272

Other funds holding KPRX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sabby Management's KPRX Position: Q2 2025 in Review

Sabby Management sold out of Kiora Pharmaceuticals (KPRX) in Q2 2025, closing a stake of 5,000 shares — an estimated $15.1K sold.

Sabby Management first reported a position in KPRX in Q3 2015 and held it in 10 quarters. The position peaked at $1M in Q2 2016. 16 funds tracked by Wall St. Rank hold KPRX as of Q2 2025.

  • Sabby Management reported no remaining Kiora Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Sabby Management sold 5,000 Kiora Pharmaceuticals shares in Q2 2025, an estimated $15.1K.
  • Sabby Management first reported a position in Kiora Pharmaceuticals in Q3 2015 and held it in 10 quarters.
  • Sabby Management's Kiora Pharmaceuticals position peaked at $1M in Q2 2016.
  • 16 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2025.

Based on Sabby Management's 13F filing for Q2 2025, filed 14 Aug 2025.